These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 13631817)

  • 21. [Purpura during the course of therapy of tuberculosis with PAS].
    LE MELLETIER J; CAULET T
    Rev Tuberc; 1952; 16(10-11):1013-5. PubMed ID: 13038334
    [No Abstract]   [Full Text] [Related]  

  • 22. [Is resistance break-through possible after INH and PAS long-term therapy in pulmonary tuberculosis by the use of INHA-PAS?].
    DEBERTSHAUSER E
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1961; 124():450-5. PubMed ID: 13884647
    [No Abstract]   [Full Text] [Related]  

  • 23. [PAS glycosuria and hyperglycemia].
    ROBEL G
    Tuberkulosearzt; 1953 Apr; 7(4):224-5. PubMed ID: 13090326
    [No Abstract]   [Full Text] [Related]  

  • 24. Study of para-aminosalicylic acid intolerance in tuberculosis of lung.
    MITCHELL RS; SCHMIDT J; CAPEL LH; SCHEEL L
    J Am Med Assoc; 1954 Sep; 156(2):124. PubMed ID: 13191936
    [No Abstract]   [Full Text] [Related]  

  • 25. An evaluation of chemotherapy in pulmonary tuberculosis. High doses of isoniazid and PAS versus daily streptomycin with high doses of isoniazid and PAS.
    BERTE SJ; BOWEN CD
    Am Rev Respir Dis; 1960 Mar; 81():407-11. PubMed ID: 13799949
    [No Abstract]   [Full Text] [Related]  

  • 26. [THE ROLE OF ACETYLATION IN THE EFFECTIVENESS OF TREATMENT WITH COMBINED ISONIAZID AND PARA-AMINOSALICYLIC ACID, AND ISONIAZID WITH PARA-AMINOBENZOIC ACID, IN PULMONARY TUBERCULOSIS].
    VITOLO A
    Bull Sci Med (Bologna); 1963; 135():396-402. PubMed ID: 14112984
    [No Abstract]   [Full Text] [Related]  

  • 27. [Two cases of fatal allergic purpura in pulmonary tuberculosis treated with I.N.H. and PAS].
    GOUDEMAND M; FOURNIER P
    Echo Med Nord; 1954 Apr; 25(4):211-5. PubMed ID: 13173404
    [No Abstract]   [Full Text] [Related]  

  • 28. Löffler's reaction to para-aminosalicylic acid.
    TUCHMAN H
    Am Rev Tuberc; 1954 Jul; 70(1):171-5. PubMed ID: 13158828
    [No Abstract]   [Full Text] [Related]  

  • 29. Acquired hypersensitivity to sodium PAS and streptomycin.
    ROWLANDS SD
    Tubercle; 1953 May; 34(5):143-4. PubMed ID: 13056998
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of pulmonary tuberculosis in its various clinical forms with streptomycin, para-aminosalicylic acid (PAS), thiosemicarbazone (TB1) and isoniazid].
    CARBAJO JJ
    Rev Clin Esp; 1955 Dec; 59(5):316-9. PubMed ID: 13310921
    [No Abstract]   [Full Text] [Related]  

  • 31. Near-fatal shock from PAS followed by Guillain-Barrés syndrome.
    BULLEY KG
    Am Rev Tuberc; 1954 Mar; 69(3):455-7. PubMed ID: 13138877
    [No Abstract]   [Full Text] [Related]  

  • 32. [Efficacy of isoniazid-PAS in pulmonary tuberculosis therapy].
    FAUSTMANN R
    Med Klin; 1956 Jul; 51(28):1193-4. PubMed ID: 13348026
    [No Abstract]   [Full Text] [Related]  

  • 33. Tuberculous pneumonia due to organisms resistant to streptomycin and isoniazid.
    KATZ S; STOREY PB; McCORMICK GF
    Am Rev Tuberc; 1954 Nov; 70(5):881-91. PubMed ID: 13207638
    [No Abstract]   [Full Text] [Related]  

  • 34. [Appearance of goiters in tuberculous treated and cured by PAS; effect of PAS on the thyroid gland of rats].
    COULAUD E
    Rev Tuberc; 1954; 18(3):261-8. PubMed ID: 13205036
    [No Abstract]   [Full Text] [Related]  

  • 35. Severe hypersensitivity reaction to para-aminosalicylic acid; report of two cases and review of the literature.
    DE ALEMQUER M
    Am Rev Tuberc; 1958 Sep; 78(3):462-7. PubMed ID: 13571603
    [No Abstract]   [Full Text] [Related]  

  • 36. [The attack therapy of pulmonary tuberculosis by the triple combination of PAS, INH and streptomycin in intravenous perfusion].
    JULLIEN MW
    J Med Bord; 1956 Jul; 133(7):685-7. PubMed ID: 13367672
    [No Abstract]   [Full Text] [Related]  

  • 37. [Intolerance to anti-tuberculosis preparations PAS, isonicotinic acid hydrazide and streptomycin].
    PORTARSKI G
    Suvr Med (Sofiia); 1958; 9(5):56-63. PubMed ID: 13603235
    [No Abstract]   [Full Text] [Related]  

  • 38. [Three years of experience with combined isoniazid and PAS therapy of pulmonary tuberculosis; caustic study].
    VERGANI F; PAGANI E; LUPACCHINI A
    Minerva Med; 1955 Nov; 46(94):1500-2. PubMed ID: 13288054
    [No Abstract]   [Full Text] [Related]  

  • 39. [Value of the immunological tests in the diagnosis of adverse effects of tuberculostatic therapy].
    Averbakh MM; Keleberda KIa; Gergert VIa; Mingazitinova DM
    Probl Tuberk; 1980 Mar; (3):27-30. PubMed ID: 6994091
    [No Abstract]   [Full Text] [Related]  

  • 40. ISONIAZID (INH), PAS and streptomycin in pulmonary tuberculosis; a control study on 443 cases.
    Acta Tuberc Scand; 1955; 30(3-4):165-94. PubMed ID: 14387824
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.